-
-
Call more information
660-596-2224 -
An advisory committee recommended on Tuesday that the FDA approve a buprenorphine implant (Probuphine) to treat patients with opioid addiction, the New York Times reports. If approved by the FDA, the matchstick-sized implant could deliver buprenorphine subdermally for 6 months. Buprenorphine is currently available in oral forms and must be taken daily. The committee voted 12 to […]
Read MoreNearly nine of 10 physicians support the CDC’s draft guidelines on opioid prescribing, according to a survey from the physician networking site SERMO. A total of 87% of 1,617 doctors surveyed said they would welcome or use the guidelines, which have been caught up in a controversy over whether the CDC was too secretive about its development […]
Read MoreThe brain has a measurable response to ibuprofen, recent research has found, and the implications of this discovery and the means with which it was made could be important for future research in analgesia and anesthesia. The study, conducted by researchers at King’s College London and Boston Children’s Hospital, looked at the pre- and postsurgical […]
Read MoreAnesthesia & Analgesia: December 2015 – Volume 121 – Issue 6 – p 1508–1516 Authors: Smolle, Karl-Heinz MD et al BACKGROUND: In cases of intensive care unit (ICU) patients without an arterial line, noninvasive continuous blood pressure monitoring could be very beneficial. The CNAP®monitor (CNSystems Medizintechnik AG) provides noninvasive, beat-to-beat blood pressure (BP) estimates using […]
Read MoreAnesthesia & Analgesia: December 2015 – Volume 121 – Issue 6 – p 1529–1533 Authors: Cho, Youn Joung MD et al BACKGROUND: The effect of commonly used anesthetics on postoperative aminotransferase levels in patients with preoperatively elevated values is unclear. METHODS: The medical records of 25,567 adult patients undergoing elective general anesthesia were retrospectively reviewed. […]
Read MoreAnesthesia & Analgesia: December 2015 – Volume 121 – Issue 6 – p 1655–1660 Authors: Bharti, Neerja DNB et al BACKGROUND: This study was designed to assess the effects of dexmedetomidine on the onset and duration of block and postoperative analgesia during supraclavicular brachial plexus block in patients undergoing upper limb surgeries. METHODS: Sixty adult […]
Read MoreAnesthesia & Analgesia: December 2015 – Volume 121 – Issue 6 – p 1580–1585 Authors: D; Chen et al BACKGROUND: The effects of general anesthetics on the hypothalamus-pituitary-adrenal axis and cortisol release in children are poorly characterized. Normal, daily fluctuation of cortisol levels complicates assessment of these effects. This study aimed to characterize the effects […]
Read MoreMore physicians will receive training on prescribing opioid pain medications as part of a White House initiative against abuse of prescription drugs and heroin use. President Barack Obama issued a memorandum yesterday requiring federal departments and agencies to provide opioid prescribing education to all “federal prescribers.” This group includes clinicians who are employees or contract […]
Read MoreIn patients with acute, nontraumatic low back pain, adding cyclobenzaprine or oxycodone/acetaminophen to naproxen alone did not improve functional outcomes or pain at 1-week follow-up in a new randomized study. “Naproxen alone was just as good as using it in combination with the muscle relaxant or the opioid,” lead author Benjamin W. Friedman, MD, Albert […]
Read MoreOn January 13, 2016, ASA and the American Society of Regional Anesthesia and Pain Medicine (ASRA) submitted formal recommendations to the Centers for Disease Control and Prevention (CDC) offering support for the proposed 2016 Guideline for Prescribing Opioids for Chronic Pain while expressing caution on its impact on therapies used to treat acute and chronic pain. The Guideline […]
Read More